Monitoring Tumour Cells in the Peripheral Blood of Small Cell Lung Cancer Patients

Clinical Cytometry

Volumn 50, Issue 3, 2002, Pages 160-167

  Kularatne, B Y ^a   Lorigan, P ^b   Browne, S ^b   Suvarna, S K ^c   Smith, M O ^a   Lawry, John ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b WESTON PARK HOSPITAL   (United Kingdom)

^c NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Circulating tumour cells; Flow cytometry; Small cell lung cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; ETOPOSIDE; IFOSFAMIDE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ANTIBODY SPECIFICITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG CANCER; LUNG SMALL CELL CANCER; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; STEM CELL; TREATMENT OUTCOME; TUMOR CELL; ANTIBODY AFFINITY; BLOOD; CELL COUNT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOLOGY; IMMUNOLOGICAL MONITORING; IMMUNOMAGNETIC SEPARATION; LONGITUDINAL STUDY; LUNG; LUNG TUMOR; METHODOLOGY; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; SMALL CELL CARCINOMA;

ANTIBODY AFFINITY; CARCINOMA, SMALL CELL; CELL COUNT; FLOW CYTOMETRY; HUMANS; IMMUNOMAGNETIC SEPARATION; LONGITUDINAL STUDIES; LUNG; LUNG NEOPLASMS; MONITORING, IMMUNOLOGIC; TREATMENT OUTCOME;

EID: 0037096392     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/cyto.10071     Document Type: Article

References (27)

1. Ross AA, Cooper BW, Lazarus HM. Detection and viability of tumour cells in peripheral blood stem cell collections from breast cancer patients using immunological and clonogenic assay techniques. Blood 1993;82:2605-2610.
2. Lawry J, Edhouse J, Reed MWR, Brown NJ. Detecting circulating tumour cells: prognostic implications. Cytometry 1994 (suppl 7);7:86.
3. Moss TJ, Sanders DG, Lasky LC, Bostrom B. Contamination of peripheral blood stem cell harvests by circulating neuroblastoma cells. Blood 1990;76:1879-1883.
4. Hamdy FC, Lawry J, Anderson JB, Parsons MA, Rees RC, Williams JL. Circulating prostate specific antigen positive cells correlate with metastatic prostate cancer. Br J Urol 1992;69:392-396.
5. Fisher ER, Turnbull RB. The cytologic demonstration and significance of tumour cells in the mesenteric venous blood of patients with colorectal carcinoma. Surg Gynecol Obstet 1955;100:102-108.
6. Moore GE, Sandberg A, Schubarg JR. Clinical and experimental observations of the occurrence and fate of tumour cells in the blood stream. Ann Surg 1957;146:580-587.
7. Engel HC. Cancer cells in the blood. A 5 to 9-year follow up study. Ann Surg 1959;149:457-459.
8. Moore GE, Sako K. The spread of carcinoma of the colon and rectum: a study of invasion of blood vessels, lymph nodes and the peritoneum by tumour cells. Dis Colon Rectum 1959;2:92-94.
9. Spyridonidis A, Bernhardt W, Fetscher S, Behringer D, Mertelsmann R, Henschler R. Minimal residual disease in autologous haematopoietic harvests from breast cancer patients. Ann Oncol 1998;9:821-826.
10. Thatcher N, Lorigan P, Burt P. Intensive combined modality therapy in small cell lung cancer. Semin Oncol 1994;21 (suppl 6):9-22.
11. Arriagada R, Chevalier T, Pignon J-P, Riviere A, Monnet I, Chomy P, Tuchais C, Tarayre M, Ruffle P. Initial chemotherapeutic doses and survival in patients with limited small cell lung cancer. N Engl J Med 1993;329:1848-1852.
12. Woll PJ, Hodgetts J, Lomax L, Bildet F, Cour-Chabernaud V, Thatcher N. Can cytotoxic dose intensity be increased using granulocyte colony stimulating factor? Randomised controlled trial of Lenograstim in small cell lung cancer. J Clin Oncol 1995;13:652-659.
13. Pettengell R, Woll J, Thatcher N, et al. Multicyclic, dose-intensive chemotherapy supported by sequential reinfusion of haematopoietic progenitors in whole blood. J Clin Oncol 1995;13:148-156.
14. Rill DR, Santona VM, Roberts WM. Direct demonstration that autologous bone marrow transplantations for solid tumours can return a multiplicity of tumorigenic cells. Blood 1994;83:3068-3076.
15. Besinger WI. Should we purge? Bone Marrow Transplant 1998;21:113-115.
16. Schulze R, Schulze M, Wishnik A. Tumour cell contamination of peripheral blood stem cell transplants and bone marrow in high risk breast cancer patients. Bone Marrow Transplant 1997;19:1223-1228.
17. Antman KH, Rowlings PA, Vaughan WP. High dose chemotherapy with autologous haematopoietic stem-cell support for breast cancer in North America. J Clin Oncol 1997;15:1870-1879.
18. Morris VL, Schmidt EE, MacDonald IC, Groom AC, Chambers AF. Sequential steps in haematogenous metastasis of cancer cells studied by in-vivo video microscopy. Invasion Metastasis 1997;17:281-296.
19. Killion JJ, Fidler J. The biology of tumour metastases. Semin Oncol 1989;16:106-115.
20. Latza U, Niedobitek G, Schwarting R, Nekarda H, Stein H. Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelia. J Clin Pathol 1990;43:213-219.
21. Gaffey MJ, Mills SE, Swanson PE, Zarbo RJ, Shah AR, Wick MR. Immunoreactivity for Ber-EP4 in adenocarcinomas, adenomatoid tumours and malignant mesotheliomas. Am J Surg Pathol 1992;16:593-599.
22. Moch H, Oberholzer M, Dalquen P, Wegmann W, Gudat F. Diagnostic tools for differentiating between pleural mesothelioma and lung adenocarcinoma in paraffin embedded tissue. Part 1 Immunohistochemical findings. Virchows Arch ic [A] 1993;423:19-27.
23. Sheibani K, Sung SS, Kezirian J, Weiss LM. Ber-EP4 antibody as a discriminant in the differential diagnosis of malignant mesothelioma versus adenocarcinoma. Am J Surg Pathol 1991;15:779-784.
24. Shah A, Prepolec M, Zarbo RJ. Optimisation of monoclonal Ber-EP4 in a two color flow cytometric DNA analysis of adenocarcinomatous effusions. Am J Clin Pathol 1990 (abstract 5);94:18.
25. Burchill SA, Bradbury MF, Pittman K, Southgate J, Smith B, Selby P. Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. Br J Cancer 1995;71:278-281.
26. Fadlon EJ, Rees RC, McIntyre C, Sharrard RM, Lawry J, Hamdy FC. Detection of circulating prostate-specific antigen positive cells in patients with prostate cancer by flow cytometry and RT-PCR. Br J Cancer 1996;74:400-405.
27. Griwatz C, Brandt B, Assmann G, Zanker KS. Immunological enrichment method for epithelial cells from peripheral blood. J Immunol Methods 1995;183:251-265.